C-reactive (CRP) in mg/dl, serum amyloid A (SAA) in mg/l and global physician assessment during 12 months of follow-up in patients with Muckle-Wells Syndrome (MWS) and overlapping MWS/chronic infantile neurological cutaneous and articular syndrome (CINCA). Panel A: patients with MWS and overlapping MWS/CINCA; panel B: patients with CINCA. Arrows represent changes in the treatment schedule (dose or frequency). Pt, patient.
Caorsi et al. Arthritis Research & Therapy 2013 15:R33 doi:10.1186/ar4184